medigraphic.com
SPANISH

Revista Biomédica

Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 1

<< Back

Rev Biomed 2025; 36 (1)

Diagnostic Challenges in Intestinal Tuberculosis: Case Presentation

Cuellar-Aguirre C, Hernández-Ascencio J, Amat-Traconis MA, Rodríguez-Córdoba MJ, Pavón-Pérez LB, Lecourtois-Amézquita MG
Full text How to cite this article

Language: Spanish
References: 16
Page: 32-36
PDF size: 130.43 Kb.


Key words:

Mycobacterium tuberculosis, intestinal tuberculosis, intestinal obstruction.

ABSTRACT

Background. Despite being preventable and curable, tuberculosis has caused a significant number of deaths throughout history. This case study emphasizes the importance of accurate and timely diagnosis, highlighting the atypical manifestations of the disease, and contributing to the knowledge and clinical management of intestinal tuberculosis.
Clinic case. A 23-year-old man, previously diagnosed with gastroenteritis and showing no signs of improvement, was admitted to the emergency department. An exploratory laparotomy was performed with a presumptive diagnosis of intestinal obstruction. In a subsequent procedure, after receiving a positive AFB report, the obstruction was relieved without the need for resection.
Discussion. Intestinal tuberculosis is a serious disease with nonspecific symptoms, making diagnosis difficult. A biopsy is necessary for an accurate diagnosis as this presentation can mimic other pathologies.


REFERENCES

  1. World Health Organization. Tuberculosis [Internet].https://www.who.int/news-room/fact-sheets/detail/tuberculosis. 2023 Apr [cited 2023 Jun 27]. Availablefrom: https://www.who.int/news-room/fact-sheets/detail/tuberculosis.

  2. Organización Panamericana de la Salud. TB en lasAmericas_PAHO [Internet]. 2021. Available from:https://www.paho.org/es/documentos/tuberculosisamericas-informe-regional2021#:~:text=En%20este%20informe%20sobre%20la, Organización%20Mundial%20de%20la%20Salud.

  3. CENAPRECE. Situación epidemiológica México[Internet]. México; 2021 [cited 2023 Jun 27].Available from: https://www.gob.mx/ cms/uploads/attachment/file/722796/1.-SITUACION_EPIDEMIOLOGICA_2021 _preliminar.pdf

  4. Jena A, Mohindra R, Rana K, Neelam PB, Thakur DC,Singh H, Gupta P, Suri V, Sharma V. Frequency, outcomes,and need for intervention in structuring gastrointestinaltuberculosis: a systematic review and meta-analysis.BMC Gastroenterol. 2023 Feb 23;23(1):46. doi: 10.1186/s12876-023-02682-x.

  5. Sharma V. Differentiating intestinal tuberculosisand Crohn’s disease: Quo Vadis. Expert RevGastroenterol Hepatol. 2020 Aug;14(8):647-650. doi:10.1080/17474124.2020.1785870.

  6. Jha DK, Pathiyil MM, Sharma V. Evidence-basedapproach to diagnosis and management of abdominaltuberculosis. Indian J Gastroenterol. 2023 Feb;42(1):17-31. doi: 10.1007/s12664-023-01343-x.

  7. Trends in Tuberculosis, 2021 [Internet]. Centersfor Disease Control and Prevention; [cited 2023November 20]. Available from: https://www.cdc.gov/tb/publications/factsheets/statistics/tbtrends.htm

  8. Das CJ, Rednam N, Vora Z, Aggarwal A,Chandrashekhara SH, Kundra V. Abdominal visceraltuberculosis: a malignancy mimic. Abdom Radiol (NY).2023 Aug;48(8):2705-2715. doi: 10.1007/s00261-023-03939-5.

  9. Bhandari B, Snyder SA, Goldman JD. ThinkingOutside the Lungs: A Case of Disseminated AbdominalTuberculosis. Am J Case Rep. 2020 Nov 26;21:e926194.doi: 10.12659/AJCR.926194. PMID: 33239604;PMCID: PMC7703488.

  10. Kedia S, Das P, Madhusudhan KS, Dattagupta S,Sharma R, Sahni P, Makharia G, Ahuja V. DifferentiatingCrohn’s disease from intestinal tuberculosis. WorldJ Gastroenterol. 2019 Jan 28;25(4):418-432. doi:10.3748/wjg.v25.i4.418. PMID: 30700939; PMCID:PMC6350172.

  11. Sanai FM, Bzeizi KI. Systematic review: tuberculousperitonitis--presenting features, diagnosticstrategies and treatment. Aliment Pharmacol Ther.2005 Oct 15;22(8):685-700. doi: 10.1111/j.1365-2036.2005.02645.x.

  12. Chow KM, Chow VC, Hung LC, Wong SM, Szeto CC.Tuberculous peritonitis-associated mortality is highamong patients waiting for the results of mycobacterialcultures of ascitic fluid samples. Clin Infect Dis. 2002Aug 15;35(4):409-13. doi: 10.1086/341898. Epub 2002Jul 17. PMID: 12145724.

  13. Eraksoy H. Gastrointestinal and Abdominal Tuberculosis.Gastroenterol Clin North Am. 2021 Jun;50(2):341-360.doi: 10.1016/j.gtc.2021.02.004.

  14. Cheng W, Zhang S, Li Y, Wang J, Li J. Intestinaltuberculosis: clinico-pathological profile and theimportance of a high degree of suspicion. Trop Med IntHealth. 2019 Jan;24(1):81–90.

  15. Uzunkoy A, Harma M, Harma M. Diagnosis of abdominaltuberculosis: Experience from 11 cases and review of theliterature. World J Gastroenterol. 2004;10(24):3647.

  16. Lee WK, Van Tonder F, Tartaglia CJ, Dagia C, CazzatoRL, Dud- dalwar VA, et al. CT appearances of abdominaltuberculosis. Clin Radiol. 2012 Jun;67(6):596–604.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Biomed. 2025;36